• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT HBALC GEN. 3; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT HBALC GEN. 3; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Catalog Number 05336163190
Device Problems High Test Results (2457); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/12/2023
Event Type  malfunction  
Manufacturer Narrative
The c502 module serial number was (b)(6).The last preventive maintenance visit was in (b)(6) 2023.The field service engineer (fse) identified broken hoses on the instrument and replaced them.Reagent pipettes, sample pipettes and syringe valves were replaced, instrument check results were within specification.Calibration and qc were acceptable.Repeatability testing was performed with a different analyzer and the results were comparable.The service actions resolved the issue.
 
Event Description
The initial reporter questioned the results for multiple patient samples tested for tina-quant hba1c gen.3 (hba1c) on a cobas 6000 c (501) module.Discrepant results were provided for 4 patient samples.Patient 1 initial result was 7.6%.The repeat result was 5.5%.On (b)(6) 2023 patient 2 initial result was 11.9%.This result was reported outside of the laboratory where it was questioned as the patient is not a diabetic.On (b)(6) 2023 the repeat result was 4.9%.On (b)(6) 2023 patient 3 initial result was 7.5%.The repeat result was 5.7 %.On (b)(6) 2023 patient 4 initial result was 7.4%.The repeat result was 5.6 %.The questionable results for patients 1, 3 and 4 were not reported outside of the laboratory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT HBALC GEN. 3
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17515302
MDR Text Key321087488
Report Number1823260-2023-02607
Device Sequence Number1
Product Code LCP
UDI-Device Identifier04015630926275
UDI-Public04015630926275
Combination Product (y/n)Y
Reporter Country CodeCO
PMA/PMN Number
K102914
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05336163190
Device Lot NumberACK5P000001LYO9CAC
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-